CerebrAlcare Pills on CereBral Small VesseL DiseasE (CABLE) trial: rationale and design
{{output}}
Rationale: Cerebral small vessel disease (CSVD) is responsible for 25% of ischaemic strokes and 45% of dementia cases. Currently, therapies targeting individual mechanisms have not shown significant efficacy. As CSVD involves mul... ...
